Sefal Pharmaceutics Private Limited - Due diligence report

A 360° intelligence report on Sefal Pharmaceutics Private Limited: trust score, financial health, credit view, compliance, directors, growth…

1999-03-10 Punjab, Punjab Strike Off Unlisted Active Compliant
Share
SP Sefal Pharmaceutics Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Sefal Pharmaceutics Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
56/100
Trust Score
Moderate

Sefal Pharmaceutics Private Limited is assessed as Moderate with a Trust Score of 56/100. Sefal Pharmaceutics Private Limited is a private limited indian non-government company incorporated in 1999, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and moderate financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Sefal Pharmaceutics Private Limited snapshot & full profile →

Financial Health › Good
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Weak

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
56/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
30/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
55/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
50/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
40/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.

Charges position: 0 open (-) · 1 satisfied (8.00 Lakh).

Banking relationships (from registered charges)
LenderChargesAmount
Punjab National Bank1 48.0 cr
Compliance Score: 30/100 Caution Indicated
  • Company status is "Strike Off" - not Active.
  • Last balance sheet is for Mar 2019 - filings overdue.
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
SHAHEER ZAMAN ARIZ 01234567 Director 01/04/2018 6 yrs Approved
YASHPAL ARORA 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2019 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 50 · Distress 40
Growth signals & trust indicators
Latest year revenue grew 38%.
Operating for 27+ years.
Distress signals & risk flags
Losses deepening year-on-year.
Statutory filings appear overdue.
Adverse company status: Strike Off.
Compliance score is weak (30/100).
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence41/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 3 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment44/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view53/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 13 events
30 Sep 2019
Last AGM held
Annual general meeting
31 Mar 2019
Latest balance sheet
Filed with ROC
10 Jun 2015
Charge satisfied
Punjab National Bank
15 Oct 2014
Director ceased
RAJESH KUMAR SHARMA
Director ceased
TARUN KUMAR DAWAR
Director ceased
HUKAM CHAND SHARMA
01 Oct 2014
Director ceased
SHAHEER ZAMAN ARIZ
Director ceased
YASHPAL ARORA
22 Sep 2014
Director appointed
SHAHEER ZAMAN ARIZ (Director)
Director appointed
YASHPAL ARORA (Director)
20 May 2011
Director ceased
SUNITA SHARMA
28 Oct 2002
Charge created
Punjab National Bank - 8.00 Lakh
10 Mar 1999
Incorporated
Registered with Roc Chandigarh
10

Key Observations

Auto-generated from the data above
Revenue declined 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
Net worth is positive.
2 active director(s) / partner(s); board looks stable and experienced.
All 1 registered charge(s) stand satisfied - past borrowings repaid.
Promoters hold a dominant controlling stake as per the FY 2019 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Satyam Securities & Finance Pvt. Ltd. U67120WB1995PTC069400 Kolkata, West Bengal, India
Anmol Steel Processors Private Limited U27100MH1994PTC078196 Navi Mumbai, Maharashtra, India
Osmanabad District Farmers' Food Producer Company Limited U01400MH2016PTC273405 Osmanabad, Maharashtra, India
Rangana Fashions Private Limited U18204WB2013PTC195841 Kolkata, West Bengal, India
Cenlub Systems India Pvt Ltd U29120HR1994PTC032224 Harayan, Haryana, India
Asian Education Development Private Limited U80903WB2005PTC101745 Kolkata, West Bengal, India
Kashur Crafts Private Limited U74900JK2012PTC003443 Jammu, Jammu & Kashmir, India
Karan Liquors Private Limited U15512MH1999PTC123333 Nasik, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Sefal Pharmaceutics Private Limited before audits and certifications: compliance score 30/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Sefal Pharmaceutics Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 50/100, margin trends, ownership structure and peer set for Sefal Pharmaceutics Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 56/100, distress signals and MSME payment-delay disclosures - know whether Sefal Pharmaceutics Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Sefal Pharmaceutics Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Sefal Pharmaceutics Private Limited an active company?

Sefal Pharmaceutics Private Limited has MCA status “Strike Off” with a compliance score of 30/100 (Caution Indicated).

Is Sefal Pharmaceutics Private Limited financially healthy?

Sefal Pharmaceutics Private Limited has a Financial Health Score of 55/100 (Moderate) based on its filed financial statements.

Should I do business with Sefal Pharmaceutics Private Limited?

Its overall Trust Score is 56/100 (Moderate). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Sefal Pharmaceutics Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Sefal Pharmaceutics Private Limited have loans or charges against its assets?

No open charges - all 1 registered charge(s) stand satisfied, indicating past borrowings were repaid.

Is Sefal Pharmaceutics Private Limited up to date with its ROC filings?

Last balance sheet is for Mar 2019 - filings overdue. Overall compliance score: 30/100 (Caution Indicated).

Is it risky to lend to Sefal Pharmaceutics Private Limited?

Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.